Pregnant women are not considered high-risk populations and do not receive the same attention from the medical community as older individuals and those with underlying medical conditions. Analysis of new data could convey the social and medical vulnerability of pregnant women. Tissue and blood specimens collected during prenatal care and delivery could determine the population-based estimate of asymptomatic SARS-CoV-2 infections in pregnant women. Currently, the limited available data suggests that pregnant women are not susceptible for severe clinical manifestations of Covid-19. However, case reports lack a large sample pool and are at risk for sampling error. Additionally, reports differ as to whether vertical transmission of SARS-CoV-2 is possible.